arms. In the meta-analysis of RCTs of adverse events, it is unclear whether trials with zero 32 events in both arms provide any information for the summary risk ratio (RR) or odds ratio 33 (OR). Studies with zero events in both arms are usually excluded in both frequentist and
excluding studies with no events in both arms for meta-analyses introduced bias into the 66 pooled estimates when there was no true treatment effect.
67
Another approach uses a continuity correction (CC) of 0.5 for each cell [6, 7] . Sweeting et al. 68 [8] have proposed different CCs that perform better if the number of patients in the treatment 69 and control groups are severely imbalanced. Based on simulation studies, [4] suggests that 70 deleting trials with no events in either arm or adding CCs can introduce bias to the calculation 71 of effect measure(s).
72
Various statistical methods have been proposed for using and combining information from 73 trials with no events. A principled approach is to assume that the number of events given n 74 (the number of patients in a treatment group) and the true risk follows a binomial distribution.
75
Kuss [4] used beta-binomial regression methods to make inferences about OR, RR, and risk 76 difference. Kuss's approach assumes that events in the treatment groups are binomially 77 distributed, i.e. the likelihood for the observed events is the binomial distribution, and it can 78 handle studies with no events. Cai et al. [9] , proposed a method that uses the idea of 79 conjugacy in the same way as the beta-binomial model. They used Poisson models for both 80 fixed effect (FE) and random effects (RE) MA to make inferences about the RR between two 81 treatment groups. Bohning et al. [10] proposed a Poisson model for RE and concluded that 82 these techniques returned almost the same results as the Mantel-Haenszel (MH) method.
83
Other methods along these lines can be found in serveral other publications [11] [12] [13] [14] [15] [16] [17] [18] [19] .
84
Another approach to the MA of rare events is to take a fully probabilistic, Bayesian approach.
85
Here, after the specification of prior distributions for all relevant parameters of the analysis 86 model, the data and application of Bayes's theorem allows obtaining posterior distributions 87 for all relevant parameters [20] . Smith (1995) and Warn [21, 22] showed how to implement a 88 fully Bayesian FE and RE meta-analysis with exact binomial likelihood using WinBUGS.
89
This of course needs a decision about the prior distributions to be used that could reflect 90 expert opinion or be derived from external available information [23] , or that could be set to 91 reflect vague prior information. In an MA of rare events, the data contain limited information, and the information of the prior distributions is expected to contribute to the posterior 93 distribution. Sweeting et al. [8] investigated, among other approaches, Bayesian inference in 94 the FE meta-analysis in situations with rare events, and concluded that the method provided 95 good coverage in all scenarios investigated. However, they excluded a priori trials with no 96 events in both arms from the MA.
97
We used a Bayesian approach to conduct the MA of studies with rare events to estimate the 98 odds ratio, more precisely the log of the odds ratio, and specifically assessed the importance 99 of (1) excluding yes or no trials with zero events in both arms, and (2) the choice of priors for 100 the true OR and τ for the heterogeneity in case of RE meta-analyses. We chose the OR as the 101 target effect measure for ease of implementation because it is almost identical to the risk ratio 102 in rare event situations and allows easier model implementation using the logit function. In
103
Section 2, we define the statistical model and the different types of priors to be used both in
104
FE and RE meta-analyses. In Section 3, we describe a simulation study and the range of 105 scenarios in which we varied assumptions about true OR, the heterogeneity τ in RE standard 106 deviation, the risk in the control group, the total number of patients in treatment and control 107 groups, and the randomization ratio in the studies. In Section 4, we present the results of the 108 simulation studies. In Section 5, we reanalyze studies on the cardiovascular risk of Two approaches can be used to combine study findings:
113
1) The FE MA assumes that the treatment effect is the same in all of the studies. For FE, we 114 consider that observed variation is caused by sampling variation.
115
2) The RE MA assumes that there is a variation of the true treatment effect across studies 116 (heterogeneity). Therefore, one makes additional assumptions on how the study-specific 117 treatment effects vary. In the binary case, one commonly assumes that the study-specific 118 log(ORi) follow a normal distribution, which then implies that one also estimates the standard 119 deviation τ of this normal distribution [24] . No less than 16 methods have been identified to 120 estimate τ or τ-squared [25] . In situations with rare events, it is particularly challenging to 121 estimate τ and the choice of the prior distributions for τ is expected to be important. scale has been proposed and used in previous studies [8, 21, 22, 27] . Therefore, we used a normal distribution with a mean of zero and SDs of 10 and 100 (precisions of 0.01 and 153 0.0001). To cover very small baseline risks, it seems reasonable to use these values for SDs.
154
We also used uniform distribution with range of 20, which, when back transformed to the 155 risk scale, has a substantial mass close to zero, but is bounded away from zero at 2 × 10 -/ . standard deviation (9). In addition to this structural assumption, one needs to specify 162 prior distributions for both the mean (8) and the standard deviation (9). To reflect a rare 163 events situation, we chose a uniform distribution U(-6 to -3) for 8 and U(0 to 1) for 9.
164
These specifications provide a 95% prior interval of 0.16% to 7.0% for the risk in the 165 control group.
167
2.2 Additional model structure and assumptions for the RE MA
168
In the FE MA, we assumed a common true log(��) for all studies. In the RE MA we assume 169 that the true log(�� � ) from a normal distribution with mean log(��) and a standard 170 deviation (?) which quantifies between-study heterogeneity [24] . We have
.
172
We specified a ��7���(�1�� = 0, @A = 10) distribution as the prior distribution for 173 log(��) and investigated several prior distributions for ? as given in Table 2 . Because it is particularly challenging to estimate τ in situations with rare events, we expected the 175 specification of the prior distributions for τ to be important. Working on the log(�� � ) implies 176 We conducted a simulation study to assess coverage of the 95% CIs and bias for log(��)
186
estimates. For the data simulations, we defined the following scenarios: Table 3) .
208
� Sample size of a single study: We also used a uniform distribution to simulate the 209 sample size of each study. improved when information in the control group increased (ratio 2,4), and estimates for 247 true log(OR) were less biased ( Table S8) . Estimates of 01��(0.5, 0.5) in all the scenarios 248 were less biased and had better coverage than 01��(1, 1). Excluding studies with zeros in 249 both arms did not affect coverage or bias for true log(OR).
250
b. The weakly informative priors reached an average coverage of 94.6%, and bias showed a 251 small negative change of the true log(OR). Almost all priors performed similarly for null 252 effect and log(2). For different ratios, when we increased the proportion of zeros in both arms, bias increased slightly in a negative direction, but coverage was roughly the same.
254
The uniform and normal distribution with SD of 100 behaved similarly with respect to increasing the information on the control group, the coverage dropped to 93% and the 276 bias increased in the negative direction. For τ = 0.5, the observed coverage was lower 277 for 1:1 randomization than τ = 0.2 but similar to the other randomization scenarios.
278
In summary, uniform distribution is a poor choice to account for heterogeneity in RE
279
MA due to high bias from true log(OR). 
282
The mean coverage for log(OR) was similar for all the specified priors for � �� , but 283 different for scenarios with higher true heterogeneity τ = 0.5, on average 93.5% and 284 85%, respectively. Bias was smaller for τ = 0.2 than τ = 0.5 for both true log(OR).
285
Both mean coverage and bias were similar for low or high proportions of zeros in 286 both arms irrespective of true log(OR). For different randomization scenarios (1:1, and the estimates were biased for true log(OR) with no specific direction. There was a 300 clear pattern of increase in the coverage when we had more than 30% zeros in both 301 arms for 0.5 heterogeneity scenarios ( Table 5 and Table 6 ).
303
Results for τ ~ exp(2) were very similar to τ ~ half-normal(mean = 0.5) in all the aspects
304
( Figures S3 and S4 , Tables S11 and S12).
305
In general, for all the RE Bayesian methods in the different data scenarios, the average 306 coverage and bias were almost identical whether studies with no events were included or 307 excluded. Bayesian methods provide good coverage of 94% on average, slightly higher than 308 coverage when using the MH method, 92.6%, but both methods have a slight bias of the point 309 estimate for the true log(OR). For log(1), null effect, bias was surprisingly large, especially 310 for the scenarios in which there was high heterogeneity (0.5). By increasing the information 311 in the control group, we observed an increase in bias, but coverage remained similar. As the 312 proportion of zeros in the data increased, the hierarchical model with half-normal prior for ?
313
showed better coverage and gave a less biased estimate compared to using a uniform 314 distribution for ?. Estimates from the MH method displayed evidence of bias and poor 315 coverage because the method was unable to account for heterogeneity when the standard 316 deviation in the RE data generation scenario was high (0.5). We assigned treatment vs. control group for the ratio of group sizes b deletion is a logical argument; zero means trials with zero in both arms are excluded from the analyses. c The Gelman and Rubin diagnostic is used to check the convergence of multiple mcmc chains run in parallel. d Percentage of trials with no events in both arms. The Bayesian methods are illustrated with data from a meta-analysis of 48 comparative trials 333 that examine the possible cardiac toxicity of Rosiglitazone in RCTs designed to study 334 cardiovascular morbidity and mortality. Rosiglitazone, a Type II diabetes medicine, was 335 introduced in 1999 and is known to reduce blood glucose and glycated hemoglobin levels.
317

336
Adverse events of Rosiglitazone were studied and categorized as rare events. We used the 337 MA data, which [27] also used. Events are rare for myocardial infarction (MI): 26 trials had 338 zero in one arm, 10 trials had zero in both arms. The rare events problem is more pronounced 339 for cardiovascular (CV) death since 25 studies had no events in both arms, and 17 had one 340 arm with no event (the full data set is in supplemental Table S1 ). We illustrated the situation 341 with this example using a selection of our Bayesian methods, and compared the results to the 342 MH and Peto methods. We also compared our results with those reported by [11] , and logistic 343 regression (LR) by [27] . Shuster's RE model estimation is higher than our estimations with wider confidence 358 interval than our CIs. 
377
The high sensitivity to the choice of priors in CV death of Bayesian methods can be 378 explained due to very low event rate, 0.5%, while for MI it is almost 2%. proposed and the results obtained seem to depend on the approach chosen [4, 8, 10, 14, 18, 384 30]. In addition some computational difficulties might occur, especially if one attempts to use 385 a random-effects model because the available information is low when analyzing rare events.
386
Here we focused on assessing the variability of the results, in terms of bias and coverage, for 
402
For the simulated data scenarios with varying true log(OR) across the studies in the MA, the 403 results of the Bayesian meta-analyses were also sensitive to the specification of the prior 404 distributions for heterogeneity parameter ?. We found that using a uniform prior distribution 405 from 0 to 2 resulted in high bias and lower coverage. Also, using lognormal distribution 406 suggested by Turner et al. [28] for ? D resulted in slightly better results compared to uniform 407 distribution but, using an informative prior exemplified by half-normal with mean = 0.5 for ?
408 performed better.
409
In summary, in Bayesian MA of rare events the bias for the point estimate for the log(OR)
410
and the coverage of the Bayesian CIs were similar whether studies with no events in both 411 arms were excluded or not. However, bias and coverage were sensitive to the specification of 412 the prior distributions for risk in the baseline groups and for the between-study heterogeneity. 
